Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Cosmos Health Inc.

COSM · Nasdaq · CIK 0001474167 · Healthcare · Medical Distribution

INSIDER SIGNAL

53.7 / 100

2 buyers · 5 purchase transaction lines · $457.1K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleModerate
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+14.0 / 35
Purchase size+14.1 / 25
Role+13.0 / 20
Recency+2.6 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Role scores low · most senior buyer: Chief Executive Officer (CEO, chair and 10% owners score lowest)
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Siokas GrigoriosChief Executive Officer
○●●●●
Terzis GeorgiosChief Financial Officer
○●○
Karkantzos Theodoros ChristosDirector
○
Hoidas John JamesDirector
○
Demetriades Demetrios G.Secretary
○
Bhutawala SuhelDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION91%Largest buyer: Siokas Grigorios · $415.1K
CLUSTER BUYING · 15D2 insidersPeak activity: 2026-06-10–2026-06-16

Roles in the peak window: Chief Executive Officer, Chief Financial Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

53.7 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 54.2
  2. 54.1
  3. 54.0
  4. 53.9
  5. 53.7

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

21Purchases
0Sales
8Other Form 4 lines
29SEC filings · 365 days
BUYING5 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER8 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+32.8%
3M
+9.1%
6M
+12.0%
12M
-68.3%

Volatility & liquidity

Volatility
96.7%
Beta
—
Avg daily value
USD 1.2M

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-29.3%
ROE
-103.9%
Industry
Medical Distribution

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
2,559,806
Previous report
3,021,093
Avg daily volume
5,053,638
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-30Siokas GrigoriosPurchase (P)Common Stock, par value $.001349,825USD 0.20USD 69,965SEC filing ↗
2026-07-29Siokas GrigoriosPurchase (P)Common Stock, par value $.001766,284USD 0.18USD 137,931SEC filing ↗
2026-06-16Terzis GeorgiosPurchase (P)Common Stock, par value $.001168,135USD 0.25USD 42,034SEC filing ↗
2026-06-11Siokas GrigoriosPurchase (P)Common Stock, par value $.001218,447USD 0.21USD 45,874SEC filing ↗
2026-06-10Siokas GrigoriosPurchase (P)Common Stock, par value $.001701,447USD 0.23USD 161,333SEC filing ↗
2026-02-12Siokas GrigoriosPurchase (P)Common Stock, par value $.001388,532USD 0.37USD 143,757SEC filing ↗
2026-02-11Siokas GrigoriosPurchase (P)Common Stock, par value $.001291,262USD 0.41USD 119,417SEC filing ↗
2026-01-23Siokas GrigoriosPurchase (P)Common Stock, par value $.00190,325USD 0.50USD 45,162SEC filing ↗
2026-01-20Siokas GrigoriosPurchase (P)Common Stock, par value $.001353,321USD 0.50USD 176,660SEC filing ↗
2026-01-14Siokas GrigoriosPurchase (P)Common Stock, par value $.001493,495USD 0.45USD 222,073SEC filing ↗
2026-01-12Siokas GrigoriosPurchase (P)Common Stock, par value $.001113,185USD 0.50USD 56,592SEC filing ↗
2026-01-08Siokas GrigoriosPurchase (P)Common Stock, par value $.001156,190USD 0.52USD 81,219SEC filing ↗
2026-01-07Siokas GrigoriosPurchase (P)Common Stock, par value $.001124,880USD 0.52USD 64,938SEC filing ↗
2026-01-06Siokas GrigoriosPurchase (P)Common Stock, par value $.001133,953USD 0.54USD 72,335SEC filing ↗
2025-12-19Siokas GrigoriosPurchase (P)Common Stock, par value $.00188,314USD 0.49USD 43,274SEC filing ↗

Form 4 evidence

29 transaction lines in the latest 365-day window; 136 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-30Siokas GrigoriosPurchase (P)Common Stock, par value $.001349,825USD 0.20USD 69,965SEC filing ↗
2026-07-29Terzis GeorgiosAward / grant (A)Common Stock, par value $.001328,407USD 0.18USD 59,113SEC filing ↗
2026-07-29Siokas GrigoriosPurchase (P)Common Stock, par value $.001766,284USD 0.18USD 137,931SEC filing ↗
Show recent Form 4 evidence (29 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-07-30Siokas GrigoriosPurchase (P)Common Stock, par value $.001349,825USD 0.20USD 69,965SEC filing ↗
2026-07-29Terzis GeorgiosAward / grant (A)Common Stock, par value $.001328,407USD 0.18USD 59,113SEC filing ↗
2026-07-29Siokas GrigoriosPurchase (P)Common Stock, par value $.001766,284USD 0.18USD 137,931SEC filing ↗
2026-06-16Terzis GeorgiosPurchase (P)Common Stock, par value $.001168,135USD 0.25USD 42,034SEC filing ↗
2026-06-11Siokas GrigoriosPurchase (P)Common Stock, par value $.001218,447USD 0.21USD 45,874SEC filing ↗
2026-06-10Siokas GrigoriosPurchase (P)Common Stock, par value $.001701,447USD 0.23USD 161,333SEC filing ↗
2026-05-19Terzis GeorgiosAward / grant (A)Common Stock, par value $.001850,000USD 0.28USD 238,000SEC filing ↗
2026-05-19Siokas GrigoriosAward / grant (A)Common Stock, par value $.0012,350,000USD 0.28USD 658,000SEC filing ↗
2026-05-19Karkantzos Theodoros ChristosAward / grant (A)Common Stock, par value $.00120,000USD 0.28USD 5,600SEC filing ↗
2026-05-19Hoidas John JamesAward / grant (A)Common Stock, par value $.00120,000USD 0.28USD 5,600SEC filing ↗
2026-05-19Demetriades Demetrios G.Award / grant (A)Common Stock, par value $.00120,000USD 0.28USD 5,600SEC filing ↗
2026-05-19Bhutawala SuhelAward / grant (A)Common Stock, par value $.00120,000USD 0.28USD 5,600SEC filing ↗
2026-05-19Aslidis AnastasiosAward / grant (A)Common Stock, par value $.00140,000USD 0.28USD 11,200SEC filing ↗
2026-02-12Siokas GrigoriosPurchase (P)Common Stock, par value $.001388,532USD 0.37USD 143,757SEC filing ↗
2026-02-11Siokas GrigoriosPurchase (P)Common Stock, par value $.001291,262USD 0.41USD 119,417SEC filing ↗
2026-01-23Siokas GrigoriosPurchase (P)Common Stock, par value $.00190,325USD 0.50USD 45,162SEC filing ↗
2026-01-20Siokas GrigoriosPurchase (P)Common Stock, par value $.001353,321USD 0.50USD 176,660SEC filing ↗
2026-01-14Siokas GrigoriosPurchase (P)Common Stock, par value $.001493,495USD 0.45USD 222,073SEC filing ↗
2026-01-12Siokas GrigoriosPurchase (P)Common Stock, par value $.001113,185USD 0.50USD 56,592SEC filing ↗
2026-01-08Siokas GrigoriosPurchase (P)Common Stock, par value $.001156,190USD 0.52USD 81,219SEC filing ↗
2026-01-07Siokas GrigoriosPurchase (P)Common Stock, par value $.001124,880USD 0.52USD 64,938SEC filing ↗
2026-01-06Siokas GrigoriosPurchase (P)Common Stock, par value $.001133,953USD 0.54USD 72,335SEC filing ↗
2025-12-19Siokas GrigoriosPurchase (P)Common Stock, par value $.00188,314USD 0.49USD 43,274SEC filing ↗
2025-12-15Siokas GrigoriosPurchase (P)Common Stock, par value $.001168,472USD 0.42USD 70,758SEC filing ↗
2025-11-28Siokas GrigoriosPurchase (P)Common Stock, par value $.00176,360USD 0.64USD 48,870SEC filing ↗
2025-11-25Siokas GrigoriosPurchase (P)Common Stock, par value $.00155,732USD 0.63USD 35,111SEC filing ↗
2025-11-21Siokas GrigoriosPurchase (P)Common Stock, par value $.00156,080USD 0.68USD 38,134SEC filing ↗
2025-11-20Siokas GrigoriosPurchase (P)Common Stock, par value $.00151,315USD 0.62USD 31,815SEC filing ↗
2025-11-19Siokas GrigoriosPurchase (P)Common Stock, par value $.00161,614USD 0.65USD 40,049SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCOSM
CIK0001474167
SectorHealthcare
IndustryMedical Distribution Yahoo Finance
SEC SIC5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNasdaq

Data coverage

Local Form 4 history136 transaction lines from 2020-07-29 to 2026-07-30
61 P purchase lines · 50 S sale lines · 25 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.